KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $69.9 million.

  • Charles River Laboratories International's Share-based Compensation rose 20.36% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.7 million, marking a year-over-year decrease of 2.07%. This contributed to the annual value of $69.9 million for FY2024, which is 2.99% down from last year.
  • As of FY2024, Charles River Laboratories International's Share-based Compensation stood at $69.9 million, which was down 2.99% from $72.0 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Share-based Compensation peaked at $73.6 million during FY2022, and registered a low of $56.3 million during FY2020.
  • Over the past 3 years, Charles River Laboratories International's median Share-based Compensation value was $72.0 million (recorded in 2023), while the average stood at $71.9 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Share-based Compensation grew by 26.86% in 2021, and later dropped by 2.99% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Share-based Compensation stood at $56.3 million in 2020, then climbed by 26.86% to $71.5 million in 2021, then rose by 3.00% to $73.6 million in 2022, then dropped by 2.13% to $72.0 million in 2023, then declined by 2.99% to $69.9 million in 2024.